Gemcitabine monotherapy associated with posterior reversible encephalopathy syndrome
dc.contributor.author | Marrone, Luiz Carlos Porcello | pt_BR |
dc.contributor.author | Marrone, Bianca Fontana | pt_BR |
dc.contributor.author | Raya, Julia de La Puerta | pt_BR |
dc.contributor.author | Gadonski, Giovani | pt_BR |
dc.contributor.author | Costa, Jaderson Costa da | pt_BR |
dc.date.accessioned | 2019-05-11T02:38:15Z | pt_BR |
dc.date.issued | 2011 | pt_BR |
dc.identifier.issn | 1662-6575 | pt_BR |
dc.identifier.uri | http://hdl.handle.net/10183/194183 | pt_BR |
dc.description.abstract | Posterior reversible encephalopathy syndrome is a clinicoradiologic entity that may present with headaches, altered mental status, seizures and visual loss as well as specific neuroimaging findings. We report a case of a 74-year-old woman receiving adjuvant gemcitabine chemotherapy as monotherapy for a stage IIa pancreatic adenocarcinoma, who developed posterior reversible encephalopathy syndrome. | en |
dc.format.mimetype | application/pdf | pt_BR |
dc.language.iso | eng | pt_BR |
dc.relation.ispartof | Case Reports in Oncology. Philadelphia, USA. Vol. 4, n.1 (2011), p. 82-87 | pt_BR |
dc.rights | Open Access | en |
dc.subject | Posterior reversible encephalopathy syndrome | en |
dc.subject | Encefalopatias | pt_BR |
dc.subject | Chemotherapy | en |
dc.subject | Tratamento farmacológico | pt_BR |
dc.subject | Farmacologia | pt_BR |
dc.subject | Gemcitabine | en |
dc.title | Gemcitabine monotherapy associated with posterior reversible encephalopathy syndrome | pt_BR |
dc.type | Artigo de periódico | pt_BR |
dc.identifier.nrb | 000977618 | pt_BR |
dc.type.origin | Estrangeiro | pt_BR |
Este item está licenciado na Creative Commons License
-
Artigos de Periódicos (39951)Ciências da Saúde (10685)